chitosan has been researched along with ropinirole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bobade, N; Gaikwad, R; Khan, S; Patil, K; Yeole, P | 1 |
| Ali, J; Ali, M; Baboota, S; Bhatnagar, A; Jafarieh, O; Kumari, B; Md, S; Sahni, JK | 1 |
| Amanatiadou, EP; Bouropoulos, N; Fatouros, DG; Karavasili, C; Sygellou, L; Vizirianakis, IS | 1 |
| Andreadis, DA; Fatouros, DG; Klepetsanis, P; Kontogiannidou, E; Nazar, H; van der Merwe, SM; Zografos, AL | 1 |
| Andreadis, D; Borges, O; Chatzitaki, AT; Fatouros, DG; Jesus, S; Karavasili, C | 1 |
| Ali, J; Baboota, S; Iqubal, A; Khan, SA; Nabi, B; Nehal, N; Parvez, S; Pathak, A; Rehman, S; Yar, MS | 1 |
6 other study(ies) available for chitosan and ropinirole
| Article | Year |
|---|---|
Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Topics: Adhesiveness; Administration, Intranasal; Animals; Area Under Curve; Biological Availability; Biological Transport; Brain; Chitosan; Dopamine Agonists; Drug Carriers; Drug Delivery Systems; Gels; Hypromellose Derivatives; Indoles; Male; Methylcellulose; Nasal Mucosa; Rats; Rats, Wistar; Receptors, Dopamine D2; Swine; Temperature | 2010 |
Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Topics: Adhesiveness; Administration, Intranasal; Animals; Antiparkinson Agents; Brain; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Indoles; Male; Nanoparticles; Parkinson Disease; Particle Size; Radionuclide Imaging; Rats; Surface Properties; Swine; Technology, Pharmaceutical | 2015 |
PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Intranasal; Animals; Antiparkinson Agents; Cell Line; Cell Survival; Chitosan; Drug Carriers; Humans; Indoles; Lactic Acid; Nasal Mucosa; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep | 2016 |
Ex vivo buccal drug delivery of ropinirole hydrochloride in the presence of permeation enhancers: the effect of charge.
Topics: Animals; beta-Cyclodextrins; Chitosan; Drug Delivery Systems; Indoles; Mouth Mucosa; Permeability; Swine | 2017 |
Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety.
Topics: Animals; Chitosan; Drug Carriers; Indoles; Leukocytes, Mononuclear; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep | 2020 |
Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment.
Topics: Animals; Benzoquinones; Chitosan; Disease Models, Animal; Drug Stability; Drug Synergism; Emulsions; Female; Humans; Indoles; Male; Molecular Docking Simulation; Nanoparticles; NF-kappa B; Nigella; Oxidopamine; Parkinson Disease; Plant Oils; Rats; Tumor Necrosis Factor-alpha | 2021 |